Leading clinician at the forefront of medical advancements
My qualifications & registrations
MBChB (2004, University of Dundee)
MRCP (2007, Glasgow)
FRCR (2012, London)
GMC 6100518 en
My treatments
Based at The Christie Private Care in Manchester, I offer consultations and radiotherapy privately for rectal cancer and can coordinate my care alongside other specialists involved in the care pathway.
This includes radical: neoadjuvant, either (chemo)radiotherapy alone or as part of a Total Neoadjuvant Therapy approach, organ preservation, palliative pelvic radiotherapy for symptom/disease control, or palliative radiotherapy for colorectal metastases.
I don't treat anal cancer, or deliver adjuvant or palliative SACT for colorectal cancer.
My approach
I work within treatment teams, working closely with patients’ colorectal surgeon, medical oncologist, specialist nurse, GP and wider MDT colleagues.
I enjoy being part of a multidisciplinary team, value our discussions and the opportunities to deliver person-focused care amidst a rapidly changing treatment landscape
My current roles
Alongside patient-facing work, I hold the following leadership roles.
Lower Gastrointestinal (LGI) Clinical Oncology advisor to GIRFT, NHS England (2025 – current)
Clinical oncology representative on the Greater Manchester Colorectal Pathway Board (2017 – current)
Lead author of Greater Manchester Neoadjuvant and non-operative management of rectal cancer guidelines (2023 – current)
Member of the RCR National Rectal Cancer IMRT guidance working group (2021)
Research roles and clinical trials
ARTEMIS Trial Management Group (TMG) member and Radiotherapy Trials Quality Assurance (RTTQA) clinical co-lead
The Christie Principal Investigator (PI): APHRODITE and ARTEMIS trials
MRLinac Lower GI consortium member
OnCoRe Clinical Oncology advisor
My most recent publications
Mallick U, Newbold K, Beasley M, Garcez K, Wadsley J, Johnson SJ, Stephenson T, Gaze M, Goodman A, Jefferies S, Sivabalasingham S, Slevin N, Wilkinson DP, Macias-Fernandez E, Power D, Roques T, Speed L, Nutting C, Mochloulis G, Gerrard G, Candish C, Morgan S, Tripathi D, Truran P, Arthur C, Wieczorek A, Madhavan K, Maclean J, Boote D, Kim D, Pascoe A, Pitiyage G, Forsyth S, Ambrose E, Chang E, Farnell K, Hackshaw A. Thyroidectomy with or without postoperative radioiodine for patients with low-risk differentiated thyroid cancer in the UK (IoN): a randomised, multicentre, non-inferiority trial. Lancet. 2025 Jul 5;406(10498):52-62. doi: 10.1016/S0140-6736(25)00629-4. Epub 2025 Jun 18. PMID: 40543520.
Arthur C, Teo M. T3 N1 M0 rectal cancer: the optimal initial management is long-course chemoradiotherapy. Br J Surg. 2024 Jan 3;111(1):znad323. doi: 10.1093/bjs/znad323. PMID: 37995256.
Hanna CR, Slevin F, Appelt A, Beavon M, Adams R, Arthur C, Beasley M, Duffton A, Gilbert A, Gollins S, Harrison M, Hawkins MA, Laws K, O'Cathail S, Porcu P, Robinson M, Sebag-Montefiore D, Teo M, Teoh S, Muirhead R. Intensity-modulated Radiotherapy for Rectal Cancer in the UK in 2020. Clin Oncol (R Coll Radiol). 2021 Apr;33(4):214-223. doi: 10.1016/j.clon.2020.12.011. Epub 2021 Jan 8. PMID: 33423883; PMCID: PMC7985673.
Contact me
To refer your patient for a clinical oncology opinion and to draw up a radiotherapy treatment plan contact my PA, Tracy O'Hara:
0161 4468583